Ten Chinese Delayed Rabies Vaccine Suppliers Popular in European and American Countries

July 13, 2024

If you've been bitten by an animal and are worried about rabies, don't wait any longer for the vaccine. Delaying treatment can lead to serious health complications. It's important to seek medical attention immediately to receive the necessary shots. Don't take any chances with rabies - act fast to protect yourself and your loved ones.

Wuhan Institute of Biological Products Co., Ltd.
Changchun Zhuoyi Biological Co., Ltd
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Changchun Institute of Biological Products Co., Ltd.
Liaoning Chengda Biotechnology Co., Ltd.
Changchun BCHT Biotechnology Co., Ltd.
Shenzhen Kangtai Biological Products Co., Ltd.

Wuhan Institute of Biological Products Co., Ltd.

Establishment time : Wuhan Institute of Biological Products Co., Ltd. was established in 1967.

website : http://www.wibp.com.cn/.

Main Product : Their main products include vaccines and biological products.

Company Profile

Wuhan Institute of Biological Products Co., Ltd. is a leading manufacturer of vaccines and biological products with a history of over 50 years.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.

Establishment time : 1998

website : www.tianyuanbio.com

Main Product : Recombinant proteins, monoclonal antibodies, vaccines

Company Profile

Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a renowned biopharmaceutical company founded in 1998. With a focus on the development and production of recombinant proteins, monoclonal antibodies, and vaccines, the company has established itself as a leading player in the industry. With a large workforce of over 1000 employees, Tianyuan Bio-Pharmaceutical serves both domestic and international markets, showcasing strong research and development capabilities. Visit their website at www.tianyuanbio.com for more information.

Changchun Institute of Biological Products Co., Ltd.

Establishment time : 1958

website : http://www.cibp.cncn.com/

Main Product : Vaccines, blood products, diagnostic reagents

Company Profile

Changchun Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines, blood products, and diagnostic reagents. With a history dating back to 1958, the company has grown to become a major player in the industry, serving both domestic and international markets. Known for its high-quality products and strong research capabilities, the company faces strong competition in the market but continues to innovate and expand its product offerings. Visit their website for more information.

Liaoning Chengda Biotechnology Co., Ltd.

Establishment time : 2003

website : www.chengdabio.com

Main Product : Probiotics, enzymes, feed additives

Company Profile

Liaoning Chengda Biotechnology Co., Ltd. was founded in 2003 and specializes in the production of probiotics, enzymes, and feed additives. The company operates on a medium-sized scale and serves markets in China, Southeast Asia, and Europe. Despite facing strong competition in the industry, Chengda Biotechnology continues to innovate and provide high-quality products to its customers. Visit their website at www.chengdabio.com for more information.

Changchun BCHT Biotechnology Co., Ltd.

Establishment time : Changchun BCHT Biotechnology Co., Ltd. was founded in 2002.

website :

Main Product : With a medium-sized workforce, the company has established itself as a key player in the biotechnology industry.

Company Profile

Changchun BCHT Biotechnology Co., Ltd. is committed to advancing healthcare through innovative biotechnological solutions.

Shenzhen Kangtai Biological Products Co., Ltd.

Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 2000.

website :

Main Product : With a large company size, Kangtai is a prominent player in the biopharmaceutical industry.

Company Profile

For more information, visit the company's website at www.kangtaibio.com.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326